Photoprotective effects of apple peel nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2013, Pages 93-108

  Bennet, Devasier ^a   Kang, Se Chan ^a   Gang, Jongback ^a   Kim, Sanghyo ^a,b  

^a Gachon University College of Medicine   (South Korea)

^b Graduate Gachon Medical research Institute   (South Korea)

Author keywords

Antioxidant; Apple peel ethanolic extract; Cellular uptake; Electric cell substrate impedance sensing; Light induced damage; Phyto drugs

Indexed keywords

APPLE PEEL ETHANOLIC EXTRACT; ASCORBIC ACID; NANOPARTICLE; NATURAL PRODUCT; POLYGLACTIN; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BIODEGRADATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIPID MEMBRANE; MALE; MASS FRAGMENTOGRAPHY; MITOSIS; OXIDATIVE STRESS; PHOTOOXIDATION; PHYSICAL CHEMISTRY; PHYTOCHEMISTRY; PROCESS OPTIMIZATION; RETINA GANGLION CELL; SKIN PROTECTION; ZETA POTENTIAL;

ANTIOXIDANT; APPLE PEEL ETHANOLIC EXTRACT; CELLULAR UPTAKE; ELECTRIC CELL-SUBSTRATE IMPEDANCE SENSING; LIGHT-INDUCED DAMAGE; PHYTO-DRUGS;

APOPTOSIS; CELLS, CULTURED; FRUIT; HUMANS; MALUS; NANOPARTICLES; PARTICLE SIZE; PLANT EXTRACTS; RADIATION TOLERANCE; SKIN ABSORPTION; SKIN PHYSIOLOGICAL PHENOMENA; SUNSCREENING AGENTS;

EID: 84890890763     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S54048     Document Type: Article

References (41)

1. Markovic SN, Erickson LA, Rao RD, et al; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364-380.
2. Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer. 2004;4(1):23-35.
3. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol. 1999;135(3):275-280.
4. de Gruijl FR. Photocarcinogenesis: UVA vs UVB radiation. Skin Pharmacol Appl Skin Physiol. 2002;15(5):316-320.
5. Kielbassa C, Roza L, Epe B. Wavelength dependence of oxidative DNA damage induced by UV and visible light. Carcinogenesis. 1997;18(4):811-816.
6. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. The basal layer in human squamous tumors harbors more UVA than UVB fngerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A. 2004;101(14):4954-4959.
7. Hockberger PE, Skimina TA, Centonze VE, et al. Activation of favin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc Natl Acad Sci U S A. 1999;96(11):6255-6260.
8. Boulton M, Rózanowska M, Rózanowski B. Retinal photodamage. J Photochem Photobiol B. 2001;64(2-3):144-161.
9. Osborne NN, Lascaratos G, Bron AJ, Chidlow G, Wood J P. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br J Ophthalmol. 2006;90(2):237-241.
10. Ruffolo JJ, Ham WT, Mueller HA, Millen JE. Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest Ophthalmol Vis Sci. 1984;25(8):893-898.
11. Kvam E, Tyrrell RM. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis. 1997;18(12):2379-2384.
12. Tyrrell RM. Ultraviolet radiation and free radical damage to skin. Biochem Soc Symp. 1995;61:47-53.
13. Wlaschek M, Tantcheva-Poór I, Naderi L, et al. Solar UV irradiation and dermal photoaging. J Photochem Photobiol B. 2001;63(1-3):41-51.
14. Einspahr JG, Stratton S P, Bowden GT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol. 2002;41(3):269-285.
15. Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006;5(2): 215-237.
16. Wondrak GT. Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr Opin Investig Drugs. 2007;8(5):390-400.
17. Bennet D, Kim S. Impedance-based cell culture platform to assess light-induced stress changes with antagonist drugs using retinal cells. Anal Chem. 2013;85(10):4902-4911.
18. Nichols JA, Katiyar SK. Skin photoprotection by natural polyphenols: anti-infammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res. 2010;302(2):71-83.
19. Bonina F, Lanza M, Montenegro L, et al. Flavonoids as potential protective agents against photo-oxidative skin damage. Int J Pharm. 1996;145(1-2):87-94
20. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57(2): 171-185.
21. Cevc G, Vierl U. Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Control Release. 2010;141(3): 277-299.
22. Huang, MC, Agrios GN. Effect of scar skin and dapple apple diseases on certain groups of phenolic compounds in apple. Phytopathology. 1979;69(1):35-40.
23. Bennet D, Kim S. A transdermal delivery system to enhance quercetin nanoparticle permeability. J Biomater Sci Polym Ed. 2013;24(2):185-209.
24. Bennet D, Marimuthu M, Kim S, An J. Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery. Int J Nanomedicine. 2012;7:3399-3419.
25. Giaever I, Keese CR. A morphological biosensor for mammalian cells. Nature. 1993;366(6455):591-592.
26. Keese CR, Wegener J, Walker SR, Giaever I. Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci U S A. 2004;101(6): 1554-1559.
27. Bennet D, Kim MG, Kim S. Light-induced anatomical alterations in retinal cells. Anal Biochem. 2013;436(2):84-92.
28. Hu F, Lu R, Huang B, Liang M. Free radical scavenging activity of extracts prepared from fresh leaves of selected Chinese medicinal plants. Fitoterapia. 2004;75(1):14-23.
29. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafne particles. Environ Health Perspect. 2005;113(7):823-839.
30. Birnbaum DT, Kosmala JD, Brannon-Peppas L. Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. J Nanopart Res. 2000;2(2):173-181.
31. Peng D, Huang K, Liu Y, Liu S. Preparation of novel polymeric microspheres for controlled release of fnasteride. Int J Pharm. 2007; 342(1-2):82-86.
32. Song X, Zhao Y, Wu W, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment effciency. Int J Pharm. 2008;350(1-2):320-329.
33. Xie F, Xu Y, Wang L, Mitchelson K, Xing W, Cheng J. Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anti-cancer drugs in a human kidney cell nephrotoxicity model. Analyst. 2012;137(6):1343-1350.
34. Han IH, Choi SU, Nam DY, et al. Identifcation and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Arch Pharm Res. 2010;33(2):293-299.
35. Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47(2-3):229-250.
36. Lara MG, Bentley M V, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm. 2005;293(1-2):241-250.
37. Boyd BJ, Whittaker D V, Khoo SM, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006;309(1-2):218-226.
38. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104(1):226-232.
39. Cevc G. Rationale for the production and dermal application of lipid vesicles: In: Falco OB, Korting HC, Maibach HI, editors. Liposome Dermatics. Berlin: Springer-Verlag, 1992:82-90.
40. Cevc G, Schatzlein A, Blume G. Transdermal drug carriers: Basic properties, optimization and transfer effciency in the case of epicutaneously applied peptides. J Control Release. 1995;36(1-2):3-16.
41. Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultrafexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998;1368(2):201-215.